Muñoz-Casares, FC, Martín-Broto, J, Cascales-Campos, P, Torres-Melero, J, López-Rojo, I, Gómez-Barbadillo, J, González-Bayón, L, Sebio, A, Serrano, C, Carvalhal, S, de Souza, JA, Souza, A, Flores-Ayala, G, Fuenmayor, LJP, Lopes-Bras, R, González-López, JA, Vasques, H, Asencio-Pascual, JM. Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations. Cancers. 2024; 16(15)DOI:10.3390/cancers16152646. PMID:39123374. IF:4.400(Q2/3D).

Schmidt-Hieber, M, Ljungman, P, Gilbert, P, Knelange, N, Drozd-Sokolowska, J, Basak, G, Einsele, H, Tridello, G, Abdeljelil, NB, Kulagin, A, Balaguer-Rosello, A, Metafuni, E, Faraci, M, Gozdzik, J, Martino, R, Raiola, AM, Xhaard, A, Kuskonmaz, B, Biffi, A, Czyzewski, K, Gabriel, MA, Martínez-Lopez, J, Zaidman, I, Schlegel, PG, Gruhn, B, Krivan, G, Vicent, MG, Mikulska, M, Peric, Z, Averbuch, D, Styczynski, J, Penack, O, de la Camara, R. Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT. Eclinicalmedicine. 2026; 93DOI:10.1016/j.eclinm.2026.103792. PMID:41783087. IF:10.000(Q1/1D).

Döhner, H, Schuh, AC, Recher, C, O'Nions, J, Aldoss, I, Piérola, AA, Allred, AJ, Alonso-Dominguez, JM, Barreyro, L, Bories, P, Daskalakis, N, Della Porta, MG, D'Souza, A, Dugan, J, Esteve, J, Fathi, AT, Ferrante, L, Gaj, S, Garciaz, S, Diaz, AG, Salamero, O, Guttke, C, Gyan, E, Hiebert, B, Jabbour, E, Jentzsch, M, Kantarjian, HM, Konopleva, M, Krönke, J, Hütter-Krönke, ML, Loefgren, C, Lomas, O, Mancini, V, Mantzaris, I, Morillo, D, Packman, K, Papayannidis, C, Philippar, U, Platzbecker, U, Paniagua, SG, Sackey, N, Sauer, T, Shastri, PN, Searle, E, Tovar, N, Trancucci, D, Vallet, N, Vaughan, L, Vyas, P, Wei, AH, Rölling, C. Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations. Transplantation And Cellular Therapy. 2026; 32(2)DOI:. PMID:. IF:4.400(Q1/1D).

Rivera-Pérez, C, Morgades, M, Alonso-Saladrigues, A, Montesinos, P, Murciano, T, Gil, C, Adán, R, Esteve, J, Fuentes, C, Amigo, ML, González-Martínez, B, Coll, R, Dapena, JL, De Llano, MPQ, Fuster, JL, García-Cadenas, I, Tasso, M, Barba, P, Rives, S, Ribera, JM. Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups. ANNALS OF HEMATOLOGY. 2026; 105(4)DOI:10.1007/s00277-026-06956-8. PMID:41874722. IF:2.400(Q2/5D).

Giménez, E, Rodriguez-Belenguer, P, Solano, C, Vázquez, L, Martino, R, de la Cámara, R, Rovira, M, Espigado, I, Calvo, CM, López-Jiménez, J, Pérez, A, Bermúdez, A, Saldaña, R, Heras, I, González-Huerta, AJ, Torrado, T, Bautista, G, Perera-Alvarez, MD, González-Pinedo, L, Barba, P, Cuesta, MA, Chorao, P, Basalobre, P, Navarro, D, García-Cadenas, I, Piñana, JL. Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH-TC. JOURNAL OF MEDICAL VIROLOGY. 2026; 98(3)DOI:10.1002/jmv.70867. PMID:41823077. IF:4.600(Q1/1D).

Lopez-Pereira, P, Domínguez, SR, Martin-Moro, F, Caballero, AC, García, AL, Benito, BD, Sarto, MF, Vicente, FD, Marín, JL, Marino, SP, Jiménez-Ubieto, A, Cabirta, A, Gutiérrez, NC, Chulvi, MJL, Puyuelo, A, Prat, AM, Coello, AP, García-Lerma, E, Vilchez, SM. Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis. BONE MARROW TRANSPLANTATION. 2026; 61(2)DOI:10.1038/s41409-025-02772-2. PMID:41310181. IF:5.200(Q1/1D).

Mur, P, Pozuelo, A, Tabernero, J, Albanell, J, Bellosillo, B, Bosch, F, Briones, J, Brunet, J, Colomer, D, Domènech, M, Fontanet, JM, Matias-Guiu, X, Salazar, R, Vivanco-Hidalgo, RM, Mollà, M, Moreno, L, Prat, A, Ribera, JM, Clèries, R, Guarga, A, Espinàs, JA, Borras, JM. Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospects. Clinical & Translational Oncology. 2026; 28(3)DOI:10.1007/s12094-025-04022-9. PMID:40900393. IF:2.500(Q3/6D).

Mecklenbrauck, R, Ramiro, AV, Sträng, E, Gabdoulline, R, Elicegui, JM, Sobas, M, Pleyer, L, Turki, A, Voso, MT, Benner, A, Hernández-Sánchez, A, Tettero, JM, Gimenez, LT, Metzeler, KH, Oñate, G, Lehmann, S, Huntly, BJP, Thomas, I, Thol, FR, Heidel, FH, Valk, PJM, Döhner, K, Haferlach, T, Mills, KI, Döhner, H, Castellani, G, Ossenkoppele, GJ, Hernández-Rivas, JM, Bullinger, L, Heuser, M. Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia. LEUKEMIA. 2026; 40(3)DOI:10.1038/s41375-026-02874-w. PMID:41663622. IF:13.400(Q1/1D).